Verfasser: |
Selvarajah, Abi
Tavenier, Annerieke H.
Bor, Wilbert L.
Houben, Vital
Rasoul, Saman
Kaplan, Eliza
Teeuwen, Koen
Hofma, Sjoerd H.
Lipsic, Erik
Amoroso, Giovanni
van Leeuwen, Maarten A.H.
ten Berg, Jur M.
van ‚Äėt Hof, Arnoud W.J.
Hermanides, Renicus S. |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2021 |
Reihe/Periodikum: |
Selvarajah , A , Tavenier , A H , Bor , W L , Houben , V , Rasoul , S , Kaplan , E , Teeuwen , K , Hofma , S H , Lipsic , E , Amoroso , G , van Leeuwen , M A H , ten Berg , J M , van ‚Äėt Hof , A W J & Hermanides , R S 2021 , ' Feasibility and safety of cangrelor in patients with suboptimal P2Y 12 inhibition undergoing percutaneous coronary intervention : The Dutch Cangrelor registry ' , European Heart Journal Open , vol. 1 , no. 3 , 1‚Äď3 . https://doi.org/10.1093/ehjopen/oeab028 |
Schlagwörter: |
Cangrelor
/ P2Y12 inhibitors
/ Percutaneous coronary intervention
/ Platelet inhibition |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-29028776 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://hdl.handle.net/11370/c0e3d433-5ec9-49c4-aced-3c9ef4741cfa |